Unique challenges can affect the success of the shift from pediatric to adult care settings.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Social media platforms, public health agencies, and communities must join forces to stop the rapid spread of false information.
With the addition of 2 new live biotherapeutic products, a clinician reviews the application, storage and administration techniques for them.
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
As the first line of acute care, emergency departments are key stewards of antibiotics.
Important clinical considerations to know about resistant CMV infections.
As the first line of acute care, emergency departments are key stewards of antibiotics.
Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).
Management of this condition has been associated with antibiotic misuse. In the latest Bench to Bedside column, clinicians offer insights on therapy indications and what the latest literature reports on the condition.
The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.
There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.
Clinicians review a patient case including diagnosis, treatment, and follow-up.
The prevalence of this disease in this patient population is much higher than in the general public.
In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.
The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.
Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.
Research presented at ASHP 2024 found that concerns around the safety of COVID-19 vaccines and the credibility of information from public health authorities were the biggest drivers of vaccine hesitancy during the COVID-19 pandemic.
This market has seen a flurry of activity, as shown by a review of the latest agents.
The key is using the right dose on the right patient at the right time.
Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).
Outside of vaccines, these underutilized therapies are the best defense against severe disease.
The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.